Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

09. April 2026 23:05 ET | Quelle: Manhattan Mental Health Counseling

TRICARE Now Covers Online Therapy in New York — $0 Copay for Active-Duty Families Through MMHC

Manhattan Mental Health Counseling becomes an in-network TRICARE provider for New York, accepting TRICARE Select and Reserve Select for virtual therapy.
09. April 2026 16:21 ET | Quelle: Sobi, Inc.

Sobi reçoit l’autorisation par Santé Canada pour EMPAVELIMD (pegcétacoplan) dans le traitement de la GC3 et de la GNMP-CI primitive.

EMPAVELIMD (pegcétacoplan) est le premier traitement autorisé dans le traitement des patients adultes et pédiatriques de 12 ans et plus atteints de glomérulopathie à dépôts de C3 (GC3) ou de...
09. April 2026 16:21 ET | Quelle: Sobi, Inc.

Sobi Receives Health Canada Approval for EMPAVELI® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN

EMPAVELI® (pegcetacoplan) is the first approved treatment for C3G or primary IC-MPGN for patients 12 years and older in Canada Approval supported by Phase 3 52-week VALIANT study demonstrated reduced...
09. April 2026 13:43 ET | Quelle: Law Offices of Howard G. Smith

DEADLINE ALERT for MNDY, CWH, TCOM, ODD: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

BENSALEM, Pa., April 09, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
09. April 2026 13:29 ET | Quelle: Law Offices of Howard G. Smith

DEADLINE ALERT for ATRA, COTY, SMCI, IBRX: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

BENSALEM, Pa., April 09, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
09. April 2026 12:09 ET | Quelle: Brodsky & Smith LLC

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Cyclerion Therapeutics, Inc. (Nasdaq – CYCN), National Storage Affiliates (NYSE - NSA), Urgent.ly, Inc. (OTC Markets - ULYX), UniFirst Corporation (NYSE - UNF)

BALA CYNWYD, Pa., April 09, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason...
09. April 2026 11:59 ET | Quelle: Brodsky & Smith LLC

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Terns Therapeutics, Inc. (Nasdaq – TERN), Whitestone REIT (NYSE – WSR), Rallybio Corporation (Nasdaq – RLYB), Day One Biopharmaceuticals, Inc. (Nasdaq - DAWN)

BALA CYNWYD, Pa., April 09, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason...
09. April 2026 10:13 ET | Quelle: Research and Markets

Smith+Nephew Digital Transformation Strategy Analysis Report 2025: Accelerators, Innovation Programs, Technology Initiatives, ICT, Partnerships, Investments & Acquisitions, Network Map

Dublin, April 09, 2026 (GLOBE NEWSWIRE) -- The "Enterprise Tech Ecosystem Series: Smith+Nephew - 2025" company profile has been added to ResearchAndMarkets.com's offering. The report provides...
09. April 2026 09:00 ET | Quelle: The Rosen Law Firm PA

The Rosen Law Firm, P.A. Provides this Final Reminder of the Proposed Class Action Settlement on Behalf of Purchasers of Cummins Inc. Publicly-Traded Common Stock - CMI

INDIANAPOLIS, April 09, 2026 (GLOBE NEWSWIRE) -- The Rosen Law Firm, P.A. announces that the United States District Court for the Southern District of Indiana, Indianapolis Division has approved the...
09. April 2026 08:00 ET | Quelle: Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026

BOSTON, April 09, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with...

Vorherige Seite